About Health2Sync
Health2Sync is a digital health company that delivers personalized chronic disease management solutions, with a primary focus on diabetes care. Founded in 2013 in Taiwan, the company has grown to serve over 1 million registered users worldwide across Asia, the Middle East, and other regions. The Health2Sync platform consists of two core products: a patient-facing mobile app that allows users to log and visualize blood glucose, blood pressure, weight readings, and daily activities, and a Patient Management Platform that enables healthcare professionals to monitor and support patients remotely. The company's mission is to alleviate the problem of insufficient medical resources by empowering patients to take control of their health through smart tools and data analytics. Health2Sync integrates with various medical devices including continuous glucose monitors (CGMs), digital insulin pens, and fitness trackers to provide comprehensive health data syncing. The platform offers AI-powered features such as food recognition for meal logging and voice recording for health data entry. Clinical outcomes data shows that users with an initial HbA1c greater than 7% experience an average 2.0% drop in HbA1c after 3 months of using Health2Sync. The company has established strategic partnerships with major pharmaceutical companies including Sanofi, Novo Nordisk, and AstraZeneca, and has deployed its Patient Management Platform to over 240 clinics globally. Health2Sync is certified under ISO 27001:2022 and ISO 27017:2015 for information security management.
Mission & Story
Mission
Health2Sync aims to build a simple healthcare solution incorporating mobile, digital therapeutics, and cloud-based services to lighten the burden of managing chronic diseases every day.
Founding Story
Health2Sync was established to address the global challenge that nearly 10% of the world's population has diabetes, with more than half in Asia, yet less than 30% of people with diabetes obtain proper care on average due to inadequate medical resources. The company's first prototype was launched at the US-based TechCrunch Hardware Battlefield in January 2014.
Clinical Focus
Medical conditions and clinical areas addressed by Health2Sync.
Who It Serves
Milestones & Awards
Recent Milestones
Completed oversubscribed US$20M funding round (March 2025). Listed on Taiwan Emerging Stock Market under ticker 7851 (November 2024). Named to Forbes 'Asia 100 To Watch 2025' (August 2024). Launched DigiCoach CGM-based diabetes prevention program with Singapore Health Promotion Board (August 2024). Selected for Taiwan's Digital Care Reimbursement Project (October 2024). Reached 1 million registered users (January 2023).
Awards & Recognition
Forbes 'Asia 100 To Watch 2025', Taiwan's top 100 startups by TVCA (2024), Top 13 pioneering startups by Taiwan's National Development Council (2023), 18th National Innoaward Taiwan (2021), Top 10 Diabetes Apps globally by Healthline (2017, 2018, 2019)
Key Partnerships
Social & Media
Follow on
Latest Updates
Company Details
- Founded
- 2013
- Headquarters
- Taiwan
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 46 →
Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.